Tissue Engineering Market by Type (Synthetic Scaffold Material, Biologically Derived Scaffold Material, and Others), Application (Orthopedics & Musculoskeletal, Neurology, Cardiovascular, Skin & Integumentary, Dental, and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027

Tissue Engineering Market 

The global tissue engineering market size was valued at USD 2374 Million in 2019 and is forecasted to reach a size of USD 6815 Million by 2027 at a CAGR of 14.2% from 2020 to 2027. Key drivers of the tissue engineering market include the rising incidences of chronic diseases and trauma emergencies along with awareness regarding tissue engineering therapies. 

The technological advancements in 3D bioprinting and R&D activities will fuel the growth of the tissue engineering market in the coming years. Commercialization of tissue-engineered products and spurt in regenerative medicine use will provide huge scope for market expansion. However, high costs, strict government rules, and covid 19 restrictions will hamper the tissue engineering market growth in the subsequent years.

Trends Influencing the Global Tissue Engineering Market 

Growing diseases such as diabetes, obesity, trauma cases, and rising awareness levels

Skin loss happens due to a variety of reasons such as diabetes, thermal injuries, chronic ulcer, pressure, venous stasis, etc. Chronic wounds and injuries degrade the quality of life and lead to disability, imbalance, amputation, or even death. People are opting for therapeutic interventions through tissue-engineered skin replacements for restoring functional, structural properties to the affected skin mass. The increasing recognizance of reengineered tissues and organs has helped end the pain of debilitating diseases and wounds. This in turn will drive the growth of the tissue engineering market in the upcoming years. 

The emergence of newer technologies

3D printing, skin grafting, bioartificial organs, biomimetics, and materials are the latest technological solutions for accelerating the body’s healing capacity and stimulating regeneration. Several 3D printed constructs and scaffolding equipment have been approved to provide cellular differentiation and reconstruction of wounded body tissues. The rapid innovations and launching of a variety of advanced equipment by key players will continue further accelerating the growth of the tissue engineering market during the review period.

The rise in preference for regenerative medicine and largescale commercialization

Stem cell research and regenerative therapies are gaining traction worldwide. These biomedical and cell research methodologies have the potential to revolutionize the medical industry. They are being applied to regenerate certain body tissues and organs or growing artificial parts in laboratories for completely replacing the original organ. Bones, cartilage, blood vessels, cardiovascular repair, and bladder can be imitated artificially to restore normal functioning. Preventive care also forms an essential part of the regenerative process. Moreover, the rapid commercialization is aiding in the overall growth of the market. These factors will significantly boost the tissue engineering market growth in the future. 

Costly and covid 19 impact

There are a host of potential benefits to this industry. But the high research and development costs, lower profit margins, and escalating manufacturing prices will severely restrict the market.  It remains out of reach of the majority of the population. Moreover with the ongoing covid 19 pandemic pharmaceutical and biotech companies have shifted their focus to developing covid vaccines and research on possible treatments. All non-essential clinical trials and resource spending has been halted. The stringent government rules further complicate the process. This in turn will restrain the growth of the tissue engineering market in the subsequent years.

Tissue Engineering Market Share Analysis 

Based on type, the biologically derived scaffolding material dominated the market in 2019 and will continue to provide lucrative opportunities for growth in the tissue engineering market share due to its biodegradability, non-toxic, quick cellular matching, and easy functioning process. On the other hand, synthetic materials will grow the fastest due to their effectiveness.

Based on application, the orthopedics and musculoskeletal segment will maintain dominance in the tissue engineering market share due to growing musculoskeletal disorders and the presence of various options such as the spine, bone substitute, graft, cartilage, etc. However, the cardiovascular segment will grow rapidly due to leading innovations and research activities.

Based on region, North America will provide huge growth opportunities in the tissue engineering market share due to developed infrastructure and rising chronic diseases. The Asia-Pacific segment will grow at the highest CAGR of 16.3% due to technological advancements and disorders.

Tissue Engineering Market Segmentation

By Type

• Synthetic Scaffold Material
• Synthetic Polymer
• Others
• Biologically Derived Scaffold Material
• Collagen
• Others
• Others

By Application

• Orthopedics and Musculoskeletal
• Neurology
• Cardiovascular
• Skin and Integumentary
• Dental
• Others

By Region

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe
• Asia-Pacific
• Japan
• China
• Australia
• India
• South Korea
• Rest of Asia-Pacific
• LAMEA
• Latin America
• Middle East and Africa

By Companies

• Abbvie Inc. (Allergen Plc.)
• Braun Melsungen Ag
• Becton, Dickinson And Company (C. R. Bard, Inc.)
• Integra Lifesciences
• Organogenesis Holdings
• Sid Martin Biotech (Axogen)
• Smith & Nephew Plc. (Osiris Therapeutics)
• Tissuetech Inc.
• Vericel Corporation
• Zimmer Biomet Holdings, Inc.

Scope of Tissue Engineering Market Report